Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q34788969)
Watch
English
Overview of the pharmacology of the aromatase inactivator exemestane
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
12186378
retrieved
4 August 2017
review article
1 reference
stated in
Europe PubMed Central
title
Overview of the pharmacology of the aromatase inactivator exemestane
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
12186378
retrieved
4 August 2017
main subject
pharmacology
1 reference
based on heuristic
inferred from title
author name string
Robert W Brueggemeier
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
12186378
retrieved
4 August 2017
language of work or name
English
0 references
publication date
1 July 2002
1 reference
stated in
Europe PubMed Central
PubMed ID
12186378
retrieved
4 August 2017
published in
Breast Cancer Research and Treatment
1 reference
stated in
Europe PubMed Central
PubMed ID
12186378
retrieved
4 August 2017
volume
74
1 reference
stated in
Europe PubMed Central
PubMed ID
12186378
retrieved
4 August 2017
page(s)
177-185
1 reference
stated in
Europe PubMed Central
PubMed ID
12186378
retrieved
4 August 2017
issue
2
1 reference
stated in
Europe PubMed Central
PubMed ID
12186378
retrieved
4 August 2017
exact match
https://scigraph.springernature.com/pub.10.1023/a:1016121822916
0 references
cites work
Mechanisms of action of antiestrogens: relevance to clinical benefits and risks
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1016121822916
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mechanism and inhibition of cytochrome P-450 aromatase
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1016121822916
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Biochemical and molecular aspects of aromatase
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1016121822916
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The Effect of an Aromatase Inhibitor, 4-Hydroxy-4-Androstene- 3,17-Dione, On Estrogen-Dependent Processes in Reproduction and Breast Cancer11
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1016121822916
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Modern techniques in radiological imaging related to oncology.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1016121822916
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Theoretical considerations for the ideal aromatase inhibitor
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1016121822916
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Novel non-steroidal aromatase inhibitors: are there new perspectives in the treatment of breast cancer?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1016121822916
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of estrogen deprivation on the reproductive physiology of male and female primates
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1016121822916
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Novel aromatase and 5 alpha-reductase inhibitors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1016121822916
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Aromatase inhibitors--mechanisms of steroidal inhibitors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1016121822916
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Formestane. A review of its pharmacological properties and clinical efficacy in the treatment of postmenopausal breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1016121822916
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
6-Methylenandrosta-1,4-diene-3,17-dione (FCE 24304): a new irreversible aromatase inhibitor
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1016121822916
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacological profiles of exemestane and formestane, steroidal aromatase inhibitors used for treatment of postmenopausal breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1016121822916
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1016121822916
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Novel irreversible aromatase inhibitors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1016121822916
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Synthesis and aromatase inhibition by potential metabolites of exemestane (6-methylenandrosta-1,4-diene-3,17-dione)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1016121822916
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Exemestane (FCE 24304), a new steroidal aromatase inhibitor
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1016121822916
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The minimal effective exemestane dose for endocrine activity in advanced breast cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1016121822916
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Aromatase inhibition for breast cancer treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1016121822916
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Biology of aromatase inhibitors: pharmacology/endocrinology within the breast
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1016121822916
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Endocrinological and clinical evaluation of exemestane, a new steroidal aromatase inhibitor.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1016121822916
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Second generation aromatase inhibitor--4-hydroxyandrostenedione
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1016121822916
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: results of a phase III randomized double-blind trial. The Exemestane Study Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1016121822916
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Time-dependent inhibition of aromatase in trophoblastic tumor cells in tissue culture
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1016121822916
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mechanisms of the actions of aromatase inhibitors 4-hydroxyandrostenedione, fadrozole, and aminoglutethimide on aromatase in JEG-3 cell culture
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1016121822916
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Aromatase inhibitors and enzyme stability
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1016121822916
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Breast tumor aromatase: functional role and transcriptional regulation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1016121822916
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of in vitro exemestane activity versus other antiaromatase agents
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1016121822916
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antiaromatase agents: preclinical data and neoadjuvant therapy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1016121822916
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Aromatization of androstenedione by cultured human fibroblasts
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1016121822916
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The interconversion and aromatization of androgens by human adipose tissue
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1016121822916
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oestradiol synthesis from C19 steroids by human breast cancers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1016121822916
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Multicenter, phase II trial of exemestane as third-line hormonal therapy of postmenopausal women with metastatic breast cancer. Aromasin Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1016121822916
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Third-line hormonal treatment with exemestane in postmenopausal patients with advanced breast cancer progressing on aminoglutethimide: a phase II multicentre multinational study. Exemestane Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1016121822916
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Activity of exemestane in metastatic breast cancer after failure of nonsteroidal aromatase inhibitors: a phase II trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1016121822916
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Aromatase inhibitors in the treatment and prevention of breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1016121822916
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Arimidex (ZD1033): a selective, potent inhibitor of aromatase in postmenopausal female volunteers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1016121822916
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1023/A:1016121822916
1 reference
stated in
Europe PubMed Central
PubMed ID
12186378
retrieved
4 August 2017
Dimensions Publication ID
1050005947
0 references
Fatcat ID
release_udiu6rkn5bar5kzuz5hes5fyvu
1 reference
stated in
Fatcat
reference URL
https://api.fatcat.wiki/v0/release/udiu6rkn5bar5kzuz5hes5fyvu
retrieved
24 November 2022
based on heuristic
mapped directly with Wikidata item
PubMed ID
12186378
1 reference
stated in
Europe PubMed Central
PubMed ID
12186378
retrieved
4 August 2017
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit